SMAD3 and neoplasm: SMAD3, a downstream transcription factor of the TGFB1 pathway, was also significantly overexpressed in a large number of metastases from colon cancer patients compared with the primary tumors based on the TNMplot database (Figure 7E); however, it was downregulated when the primary tumor was compared with normal tissue.